🕵️ Akero Therapeutics ($AKRO)
SEC insider & ownership activity, last 12 months · CIK 1744659 · every row links its SEC filing
Over the last 12 months insiders sold $2.8M with no open-market buying against it. Cheng Andrew sold $1.6M through a 10b5-1 trading plan in 1 lots (Oct). One red-flag 8-K in the window: Delisting notice (3.01), Dec 9, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $2.8M (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Cheng Andrew | 0 | – | 1 | $1.6M | Oct 10, 2025 |
| Jonathan Young | 0 | – | 2 | $597K | Oct 1, 2025 |
| Timothy Rolph | 0 | – | 2 | $576K | Oct 7, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Roderick WONG, M.D. | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| General Atlantic, L.P. | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| GAP Coinvestments III, LLC | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| GAP Coinvestments IV, LLC | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| GAP Coinvestments V, LLC | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| GAP Coinvestments CDA, L.P. | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic GenPar (BERMUDA), L.P. | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| GAP (BERMUDA) L.P. | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic (LUX) S.A.R.L. | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic GenPar (LUX) SCSP | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic Partners (LUX) SCSP | 8.4% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic Partners 100, L.P. | 6.5% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic (SPV) GP, LLC | 6.5% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic GenPar, L.P. | 6.5% | 13G | May 15, 2025 | filing ↗ | |
| General Atlantic (AK), L.P. | 6.5% | 13G | May 15, 2025 | filing ↗ | |
| Wellington Management Company LLP | 5.0% | 13G | Nov 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Timothy Rolph | $2.6M | Oct 7, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Dec 9, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Dec 9, 2025 | filing ↗ |
| Delisting notice (3.01) | Dec 9, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Dec 9, 2025 | filing ↗ |
| Change of control (5.01) | Dec 9, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 9, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 2, 2025 | filing ↗ |
| Other events (8.01) | Dec 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 2, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 8, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Oct 8, 2025 | filing ↗ |
| Other events (8.01) | Oct 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 8, 2025 | filing ↗ |
| Agreement terminated (1.02) | Sep 23, 2025 | filing ↗ |